John Kwon

Array ( [id] => 5142499 [patent_doc_number] => 20070004715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders' [patent_app_type] => utility [patent_app_number] => 11/443928 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11036 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004715.pdf [firstpage_image] =>[orig_patent_app_number] => 11443928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914656 [patent_doc_number] => 07326709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Bicyclic and tricyclic heteroaromatic compounds' [patent_app_type] => utility [patent_app_number] => 11/442812 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15873 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326709.pdf [firstpage_image] =>[orig_patent_app_number] => 11442812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4444889 [patent_doc_number] => 07863268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Benzothiazinone derivatives and their use as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 12/227655 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5297 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863268.pdf [firstpage_image] =>[orig_patent_app_number] => 12227655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840402 [patent_doc_number] => 20080280888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Antibiotics Derivatives' [patent_app_type] => utility [patent_app_number] => 11/915179 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12396 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280888.pdf [firstpage_image] =>[orig_patent_app_number] => 11915179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42943 [patent_doc_number] => 07781469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Arylacetate derivatives having isoxazole skeleton' [patent_app_type] => utility [patent_app_number] => 11/920999 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38216 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781469.pdf [firstpage_image] =>[orig_patent_app_number] => 11920999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625934 [patent_doc_number] => 20060264439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Inhibitors of polo-like kinase-1' [patent_app_type] => utility [patent_app_number] => 11/436115 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7762 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264439.pdf [firstpage_image] =>[orig_patent_app_number] => 11436115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33345 [patent_doc_number] => 07786045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Aryl ether compounds and their preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 11/817996 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12635 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786045.pdf [firstpage_image] =>[orig_patent_app_number] => 11817996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205653 [patent_doc_number] => 20070027135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/432937 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027135.pdf [firstpage_image] =>[orig_patent_app_number] => 11432937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733577 [patent_doc_number] => 20060258694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'HISTONE DEACETYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/382659 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42914 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258694.pdf [firstpage_image] =>[orig_patent_app_number] => 11382659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 559091 [patent_doc_number] => 07470687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Aryl oximes' [patent_app_type] => utility [patent_app_number] => 11/429181 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24936 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470687.pdf [firstpage_image] =>[orig_patent_app_number] => 11429181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705750 [patent_doc_number] => 20060194798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Bicyclic-substituted amines as histamine-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/418699 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78007 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194798.pdf [firstpage_image] =>[orig_patent_app_number] => 11418699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683524 [patent_doc_number] => 20060199794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Spiroazacyclic compounds as monoamine receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/418322 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199794.pdf [firstpage_image] =>[orig_patent_app_number] => 11418322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826924 [patent_doc_number] => 07402590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Spiroazacyclic compounds as monoamine receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/417439 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402590.pdf [firstpage_image] =>[orig_patent_app_number] => 11417439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955446 [patent_doc_number] => 20080188470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Oxazolidinone Derivatives as Antimicrobials' [patent_app_type] => utility [patent_app_number] => 11/911576 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13511 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188470.pdf [firstpage_image] =>[orig_patent_app_number] => 11911576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 566629 [patent_doc_number] => 07465727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => '(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5-c][1,3]Benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors' [patent_app_type] => utility [patent_app_number] => 11/909747 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12251 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465727.pdf [firstpage_image] =>[orig_patent_app_number] => 11909747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22436 [patent_doc_number] => 07799779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Substituted piperidines as renin inhibitors' [patent_app_type] => utility [patent_app_number] => 11/887355 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17247 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799779.pdf [firstpage_image] =>[orig_patent_app_number] => 11887355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257277 [patent_doc_number] => 20100029628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => '2,4,5-Substituted Piperidines as Renin Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/887227 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59775 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029628.pdf [firstpage_image] =>[orig_patent_app_number] => 11887227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64028 [patent_doc_number] => 07759339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Hydroxysteroid dehydrogenase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/392297 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 50503 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759339.pdf [firstpage_image] =>[orig_patent_app_number] => 11392297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914574 [patent_doc_number] => 07326702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Substituted quinobenzoxazine analogs' [patent_app_type] => utility [patent_app_number] => 11/390810 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20340 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326702.pdf [firstpage_image] =>[orig_patent_app_number] => 11390810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330540 [patent_doc_number] => 07511036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Dihydrothiazine prodrugs of thiazolium agents' [patent_app_type] => utility [patent_app_number] => 11/390946 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11316 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511036.pdf [firstpage_image] =>[orig_patent_app_number] => 11390946 [rel_patent_id] =>[rel_patent_doc_number] =>)